ALKALI vs INDOAMIN: Stock Comparison

ALKALI METALS vs INDOAMINUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

INDOAMIN is the larger company by market capitalisation. ALKALI METALS shows a higher dividend yield and lower leverage, while INDOAMIN shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALKALI leads 2; INDOAMIN leads 9 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALKALIINDOAMIN

Valuation lens

What price are you paying?

Market CapContext only
₹78 Cr
₹928 Cr
P/E RatioSame reading
11.47x
P/B RatioSame reading
2.37x
EPSINDOAMIN has the higher reading
₹-0.63
₹4.22
Book ValueContext only
₹43.89
₹54.25
Dividend YieldALKALI has the higher reading
1.31%
0.39%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
INDOAMIN is the larger company
₹928 Cr vs ₹78 Cr
EPS
INDOAMIN has higher earnings per share
₹4.22 vs ₹-0.63
Dividend Yield
ALKALI has a higher dividend yield
1.31% vs 0.39%
Revenue Growth (TTM YoY)
INDOAMIN has faster revenue growth
11.3% vs 2.98%
EPS Growth (TTM YoY)
INDOAMIN has faster EPS growth
76% vs 0%
Qtr Sales Growth
INDOAMIN has stronger quarterly sales growth
-1.96% vs -38.87%
Qtr Profit Growth
INDOAMIN has stronger quarterly profit growth
-0.48% vs -116.04%
ROE
INDOAMIN has a higher ROE
20.14% vs 1.24%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALKALIINDOAMIN
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricALKALIINDOAMIN
Live Price₹77.25₹137.95
Day Change-2.45%-1.75%
Volume19,8011.39 L
52-Week High₹107.38₹149
52-Week Low₹46.8₹81.9
Distance from 52W High-28.06%-7.42%

Valuation

MetricALKALIINDOAMIN
Market Cap₹78 Cr₹928 Cr
P/E Ratio11.47x
P/B Ratio2.37x
EPS₹-0.63₹4.22
Book Value₹43.89₹54.25
Dividend Yield1.31%0.39%

Growth

MetricALKALIINDOAMIN
Revenue Growth (TTM YoY)2.98%11.3%
EPS Growth (TTM YoY)0%76%
Qtr Sales Growth-38.87%-1.96%
Qtr Profit Growth-116.04%-0.48%

Profitability & Leverage

MetricALKALIINDOAMIN
ROE1.24%20.14%
ROCE6.4%13.9%
Net Margin0.6%6.84%
Operating Margin5.68%11.2%
Debt to Equity0.4x0.79x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALKALIINDOAMIN
Promoter Holding68.51%58.42%
FII Holding0%0.08% 0.06 pp
DII Holding0%0%
Public Holding30.41%41.5% 0.06 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALKALI METALS and INDOAMIN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.